| Dr Pamela Jayne Amelung, MD | |
|
22 S Greene St, Baltimore, MD 21201-1544 | |
| (410) 705-5762 | |
| (410) 705-7915 |
| Full Name | Dr Pamela Jayne Amelung |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 22 S Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215998281 | NPI | - | NPPES |
| 5851858 | Medicaid | VA | |
| 064521400 | Medicaid | MD | |
| 52070603 | Other | MD | BC/BS |
| 1215998281 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | D39414 (Maryland) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | D39414 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Jayne Amelung, MD Po Box 64442, Baltimore, MD 21264-4442 Ph: (410) 705-5762 | Dr Pamela Jayne Amelung, MD 22 S Greene St, Baltimore, MD 21201-1544 Ph: (410) 705-5762 |
News Archive
Based on new evidence, the age of introduction of gluten into the infant diet - or the practice of introducing gluten during breast-feeding - does not reduce the risk of celiac disease in infants at risk, according to a Position Paper of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.
Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, announced today that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis.
Monitoring patients' health by phone can make a real difference to people with chronic heart failure, according to a study published on bmj.com.
A team of researchers from leading universities in Turkey and the United States have reported that they have identified the genetic mutation responsible for the Uner Tan Syndrome (UTS) using advanced genetic capture and sequencing technologies from Roche. The combined genomic technologies enabled the team of scientists to identify the causative mutation of this debilitating disease after years of mystery.
› Verified 2 days ago
Dr. Leonard Anang Sowah, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |